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ntegrin 
 
 
 
6
 
 
 
4 signaling proceeds through Src family kinase
(SFK)–mediated phosphorylation of the cytoplasmic tail
of 
 
 
 
4, recruitment of Shc, and activation of Ras and
phosphoinositide-3 kinase. Upon cessation of signaling, 
 
 
 
6
 
 
 
4
mediates assembly of hemidesmosomes. Here, we report
that part of 
 
 
 
6
 
 
 
4 is incorporated in lipid rafts. Metabolic
labeling in combination with mutagenesis indicates that
one or more cysteine in the membrane-proximal segment
of 
 
 
 
4 tail is palmitoylated. Mutation of these cysteines
suppresses incorporation of 
 
 
 
6
 
 
 
4 in lipid rafts, but does
I
 
not affect 
 
 
 
6
 
 
 
4-mediated adhesion or assembly of
hemidesmosomes. The fraction of 
 
 
 
6
 
 
 
4 localized to rafts
associates with a palmitoylated SFK, whereas the remainder
does not. Ligation of palmitoylation-defective 
 
 
 
6
 
 
 
4 does
not activate SFK signaling to extracellular signal–regulated
kinase and fails to promote keratinocyte proliferation in
response to EGF. Thus, compartmentalization in lipid rafts
is necessary to couple the 
 
 
 
6
 
 
 
4 integrin to a palmitoylated
SFK and promote EGF-dependent mitogenesis.
 
Introduction
 
The 
 
 
 
6
 
 
 
4 integrin is a laminin-5 receptor with unique
functions in epithelial growth and carcinoma invasion
(Mainiero et al., 1997; Shaw et al., 1997). The cytoplasmic
tail of 
 
 
 
4 is large and bears no homology to the short tails of
other integrin 
 
 
 
 subunits. Upon matrix binding, the 
 
 
 
4 tail
is phosphorylated on tyrosine and interacts with the adaptor
Shc, inducing Ras/extracellular signal–regulated kinase (ERK)
signaling (Mainiero et al., 1995, 1997). In addition, 
 
 
 
4
activates phosphatidylinositol-3 kinase (PI-3K) and Rac
(Shaw et al., 1997). Upon dephosphorylation, the 
 
 
 
4 tail
associates with the keratin cytoskeleton, leading to assembly
of hemidesmosomes (Spinardi et al., 1993; Murgia et al.,
1998; Dans et al., 2001). 
 
 
 
6
 
 
 
4 cooperates with multiple
receptor protein tyrosine kinases. Activation of the EGF
receptor (EGF-R) and Met enhances phosphorylation of 
 
 
 
4
and Shc signaling, causing disruption of hemidesmosomes
and increased cell motility and proliferation (Mariotti et al.,
2001; Trusolino et al., 2001). Conversely, matrix binding to
 
 
 
6
 
 
 
4 increases activation of ErbB2/Neu (Falcioni et al.,
1997). Regulated joint 
 
 
 
6
 
 
 
4/receptor protein tyrosine kinase
signaling promotes epithelial cell survival, proliferation, and
migration (Mainiero et al., 1997; Mariotti et al., 2001;
Weaver et al., 2002). Deregulation of this system plays a
crucial role in carcinoma invasion and growth (Shaw et al.,
1997; Mariotti et al., 2001; Trusolino et al., 2001). Mice
with a targeted deletion of the 
 
 
 
4 tail display proliferation
defects in the epidermis and intestinal epithelium, high-
lighting the physiological significance of 
 
 
 
6
 
 
 
4 signaling
(Murgia et al., 1998).
The lipid rafts—subdomains of the plasma membrane
enriched in cholesterol and glycosphingolipids—promote
membrane compartmentalization of signaling components
(Simons and Toomre, 2000). Because of the biophysical
properties of their lipid anchor, GPI-linked receptors and
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palmitoylated signaling proteins, such as certain G proteins,
H-Ras, many Src family kinases (SFKs), and eNOS, are con-
centrated in rafts (Resh, 1999). Here, we report that the
 
 
 
6
 
 
 
4 integrin is incorporated in lipid rafts in a palmitoyla-
tion-dependent manner, and this is necessary to couple the
integrin to a palmitoylated SFK (pSFK) and to promote mi-
togenic signaling.
 
Results and discussion
 
Lipid rafts are resistant to extraction in Triton X-100, and
because of their low density, float on sucrose or OptiPrep™
gradients. To examine if 
 
 
 
6
 
 
 
4 localizes to lipid rafts, HaCat
keratinocytes were solubilized in Triton X-100 and sub-
jected to sucrose gradient fractionation. The rafts were re-
covered from fractions 2 and 3, as indicated by the relative
enrichment of caveolin-1 and the pSFK Yes in these frac-
tions. The Triton X-100–soluble cellular fraction was dis-
tributed over fractions 7–10, as shown by blotting with anti-
transferrin receptor and anti-tubulin, whereas the insoluble
material remained in the pellet fraction, P (Fig. 1 A). Immu-
noblotting with anti-
 
 
 
4 showed that a significant part of
 
 
 
6
 
 
 
4 (
 
 
 
15% of the total) cofractionates with the rafts,
whereas the remainder is in the Triton X-100–soluble frac-
tion and, to a minor extent, in the pellet fraction (Fig. 1 A).
As shown in Fig. 1 B, treatment of HaCat cells with the cho-
lesterol-chelating agents methyl-
 
 
 
-cyclodextrin and saponin
disrupted the association of 
 
 
 
6
 
 
 
4 with lipid rafts. Thus, a
fraction of 
 
 
 
6
 
 
 
4 partitions in the low density fractions of
sucrose gradients in a cholesterol-dependent manner, as ex-
pected of a lipid raft component.
Antibody-mediated cross-linking was used to mimic the
effect of ligand-induced aggregation of 
 
 
 
6
 
 
 
4 and to study
its effect on the incorporation of the integrin in rafts. Frac-
tionation was on OptiPrep™ gradients. Fig. 1 C shows that
antibody-mediated ligation of 
 
 
 
6
 
 
 
4 greatly increased the
amount of integrin recovered from rafts (4–30%), whereas
cross-linking of type I MHC did not exert this effect. In ad-
dition, the amount of 
 
 
 
6
 
 
 
4 recovered from the raft fraction
of untreated suspended cells was much lower than that usu-
ally obtained from the same fraction of stably adherent cells
(compare Fig. 1 C with Fig. 1 A; 4 vs. 15%). These results
suggest that ligand-induced aggregation promotes incorpo-
ration of 
 
 
 
6
 
 
 
4 in lipid rafts.
The juxtamembrane segment of the 
 
 
 
4 tail contains a
cluster of cysteines, which may be palmitoylated (Fig. 2
A). To examine this possibility, rat bladder 804G cells ex-
pressing a wild-type (A) or a tail-less (L) human 
 
 
 
4 were
metabolically labeled with 16-[
 
125
 
I]iodohexadecanoic acid
([
 
125
 
I]IC16) palmitate analogue or [
 
35
 
S]methionine/cysteine
and were immunoprecipitated with the anti–human 
 
 
 
4
mAb 3E1. Fig. 2 B shows that 
 
 
 
4 incorporated [
 
125
 
I]IC16,
but 
 
 
 
6 did not. Deletion of the 
 
 
 
4 tail prevented palmitoy-
lation of 
 
 
 
4. In addition, treatment with alkali released the
[
 
125
 
I] radioactive signal from 
 
 
 
4, implying that the radioac-
tive palmitate analogue was attached to 
 
 
 
4 through a thio–
esther bond. Notably, 
 
 
 
4 was found to be palmitoylated to a
higher apparent stoichiometry in HaCat keratinocytes (Fig.
2 B), primary human keratinocytes, and squamous carci-
Figure 1. Incorporation of  6 4 in lipid rafts. (A) After lysis in 
Triton X-100, HaCat cells were fractionated by sucrose gradient 
ultracentrifugation. Equal aliquots were blotted with antibodies to 
 4, transferrin receptor (Trf-R), tubulin, Yes, and caveolin-1 (Cav-1). 
The percentage of  4 recovered from each fraction was estimated 
by densitometry. (B) HaCat cells were left untreated or treated with 
0.2% saponin or 10 mM M CD before lysis and ultracentrifugation. 
Fractions were probed with anti- 4. (C) HaCat cells were incubated 
in suspension with mAb W6.32 (anti-MHC) or 3E1 (anti- 4) followed 
by anti–mouse IgGs, or were treated with anti–mouse IgGs only. 
Cells were lysed in Triton X-100 and subjected to OptiPrep™ gradient 
ultracentrifugation. Blotting was with anti- 4.T
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noma A431 cells (unpublished data). Although other inte-
grin 
 
 
 
 subunits do not contain potential palmitoylation
sites, the cytoplasmic segments of 
 
 
 
3, 
 
 
 
6, 
 
 
 
8, and 
 
 
 
E con-
tain one membrane-proximal cysteine. We did not detect
any palmitoylation of 
 
 
 
3
 
 
 
1 and 
 
 
 
6
 
 
 
1 (unpublished data).
Thus, 
 
 
 
4 may be the only integrin subunit modified by
palmitoylation.
To identify the region of 
 
 
 
4 tail modified by palmitoyla-
tion, we examined various cytoplasmic deletion mutant
forms of human 
 
 
 
4 (Fig. 2 A). Metabolic labeling with
[
 
3H]palmitate revealed that mutants B and C were palmitoy-
lated as efficiently as wild-type  4. By contrast, mutants L
and E incorporated very little [
3H]palmitate (Fig. 2 C), pos-
sibly because of nonphysiological, partially compensatory
palmitoylation of Cys 732, which resides at the boundary
between the transmembrane and cytoplasmic domain of  4.
These results suggest that the membrane-proximal segment
of the tail of  4 comprises the major site(s) of palmitoyla-
tion. Next, we introduced alanine permutations at each one
of the seven membrane-proximal cysteines. None of these
individual mutations reduced palmitoylation of  4 by a sig-
nificant degree (unpublished data). However, simultaneous
replacement of the first three cysteines ( 4 Cys 3) reduced
the incorporation of [
3H]palmitate by  50%, and permuta-
tion of the first five ( 4 Cys 5) abolished it almost com-
pletely. In contrast, replacement of the last two cysteines ( 4
Cys 6–7) did not affect palmitoylation of  4 (Fig. 2 D).
These results imply that the first five cysteines in the mem-
brane-proximal segment of  4 tail comprise the major site(s)
of palmitoylation. We suspect that mutagenesis did not al-
low us to identify a single palmitoylation site in  4 because
mutation of a specific cysteine in a cluster of potential sites
may result in palmitoylation of an adjacent, not necessarily
physiological site. Finally, we examined if  6 4 localizes to
lipid rafts in a palmitoylation-dependent manner. 804G
cells expressing equivalent levels of human  4 or the palmi-
toylation-defective mutant  4 Cys 5 were subjected to Tri-
ton X-100 extraction and sucrose gradient centrifugation.
Figure 2. Palmitoylation of  4 is required for incorporation of  6 4 in rafts. (A) Constructs encoding wild-type and mutant forms of  4. 
The  4 tail contains two pairs of type III Fn-like modules (black boxes) interrupted by a connecting segment (gray dotted box). The predicted 
end of transmembrane domain (TM) and membrane-proximal segment of the tail of  4 and various alanine mutants is shown above. (B) 804G 
cells expressing wild-type (A) or tail-less (L)  4 and HaCat cells were metabolically labeled with [
35S]Met/Cys or [
125I]IC16 and immunoprecipitated 
with mAb 3E1. The indicated lane was soaked overnight in 1 M hydroxylamine before fluorography. (C) 804G cells and their derivatives 
expressing wild-type  4 (A) or the indicated mutant versions of  4 (B, C, E, and L) were metabolically labeled with [
35S]Met/Cys or [
3H]palmitate 
and immunoprecipitated with mAb 3E1. (D) 293-T cells expressing wild-type  4 (A) or the indicated mutant forms of  4 (Cys 3, Cys 5, and Cys 6,7) 
were metabolically labeled with [
35S]Met/Cys or [
3H]palmitate and immunoprecipitated with mAb 3E1. The ratio of 
3H to 
35S radioactivity 
incorporated by mutant forms of  4 was measured by PhosphorImager analysis. (E) 804G cells expressing human wild-type  4 (WT) or 
palmitoylation-defective  4 (Cys 5) were lysed with Triton X-100 and subjected to sucrose gradient ultracentrifugation. Proteins from each 
fraction were probed with anti–human  4 N20 or with anti-caveolin N20.T
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Notably, the  4 Cys 5 mutant was excluded from the lipid
raft fraction (Fig. 2 E), indicating that palmitoylation of  4
is required for incorporation of  6 4 in lipid rafts. To ex-
amine if palmitoylation of  4 and incorporation of  6 4 in
lipid rafts play a role in ligand binding, 293-T cells were
transfected with vectors encoding  6 in combination with
either  4 or  4 Cys 5. Immunoblotting and FACS
® analysis
showed that the expression levels of wild-type and mutant
 6 4 were comparable. The cells were plated on laminin-5
at 4 C because at this temperature the function of  3 1,
which also mediates adhesion to laminin-5, is suppressed
(Xia et al., 1996). Untransfected 293-T cells did not attach
to laminin-5 at 4 C, whereas cells expressing wild-type
 6 4 attached to a significant extent, indicating that adhe-
sion to laminin-5 at 4 C requires expression of  6 4. The
palmitoylation-defective   6 4 mutant promoted attach-
ment to laminin-5 as effectively as wild-type  6 4 (Fig. 3
A), suggesting that palmitoylation of  4 is not required for
 6 4-mediated binding to laminin-5. To assess the ability
of the palmitoylation-deficient mutant form of  4 to pro-
mote assembly of hemidesmosomes, we introduced  4 and
 4 Cys 5 in  4-deficient keratinocytes from a patient af-
fected by junctional epidermolysis bullosa with pyloric atre-
sia (PA-JEB). As reported previously (Gagnoux-Palacios et
al., 1997), transient transfection of PA-JEB keratinocytes
with wild-type  4 caused assembly of hemidesmosome-like
adhesions containing HD-1/plectin (Fig. 3 B) and BPAG-2
(unpublished data). Introduction of  4 Cys 5 resulted in
formation of hemidesmosome-like structures similar to
those nucleated by wild-type  4 (Fig. 3 B), indicating that
palmitoylation of  4 is not required for assembly of
hemidesmosomes. To examine the role of  4 palmitoylation
in keratinocyte adhesion, we used retroviral transduction to
generate PA-JEB keratinocytes expressing similar levels of
 4 and  4 Cys 5. PA-JEB keratinocytes expressing  4 Cys 5
adhered to laminin-5 in the presence of anti- 3 1 antibod-
ies as well as PA-JEB keratinocytes expressing wild-type  4
(Fig. 3 C), confirming that palmitoylation of  4 is not re-
quired for  6 4-mediated adhesion. Upon assembly of
hemidesmosomes, keratinocytes become more resistant to
detachment with trypsin/EDTA (Gagnoux-Palacios et al.,
2001). Analysis of the kinetics of cell detachment revealed
that  4 Cys 5 delays trypsin/EDTA-induced cell detach-
ment as effectively as the wild-type  4 (Fig. 3 D). Thus,
Figure 3. Palmitoylation of  4 is not necessary for  6 4-mediated adhesion and assembly of hemidesmosomes. (A) 293-T cells were left 
untransfected (NT) or transfected with  6 in combination with wild-type  4 or  4 Cys 5, and were then plated on laminin-5 matrix at 4 C. 
Three experiments yielded essentially identical results. (B) Immortalized  4-deficient PA-JEB keratinocytes were left untransfected (NT) or 
transiently transfected with  6 in combination with wild-type  4 or  4 Cys 5. Double-immunofluorescent staining with anti- 4 and anti–HD-1/
plectin indicates that wild-type  4 and  4 Cys 5 are both recruited to the basal cell surface and colocalize with plectin in hemidesmosome-like 
adhesions. In untransfected cells, plectin codistributes instead with the actin cytoskeleton. (C) PA-JEB keratinocytes transduced with empty 
vector (LZRS), wild-type  4, or  4 Cys 5 were plated in the presence of anti- 3 mAb PIB5 on laminin-5 matrix for 30 min at 37 C. Results are 
expressed as percentages of the adhesion of control transfectants in the absence of the inhibitory mAb. (D) PA-JEB keratinocytes stably transduced 
with empty vector (LZRS), wild-type  4, or  4 Cys 5 were plated on laminin-5 matrix for 48 h and then treated with trypsin/EDTA. The number 
of cells that had detached by the indicated times was determined by direct counting. Four experiments yielded essentially the same result.T
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 6 4-mediated adhesion and assembly of hemidesmosomes
does not require palmitoylation of  4 and incorporation of
the integrin in lipid rafts.
Prior reports have indicated that  6 4 signaling is medi-
ated by a pSFK (Mariotti et al., 2001). We asked whether
 6 4 associates with a pSFKs in lipid rafts. After antibody-
mediated ligation of  6 4, the lipid raft and the Triton
X-100–soluble fractions of HaCat keratinocytes were im-
munoprecipitated with anti- 4 and probed by blotting with
anti-panSrc, which recognizes Src, Fyn, and Yes, and as a
control, with anti- 4. We found that the lipid raft fraction
of  6 4 is associated with SFKs, but the Triton X-100–sol-
uble fraction, which is much larger, is not (Fig. 4 A). Upon
introduction in HaCat cells, a GPI-linked form of GFP lo-
calized to lipid rafts, but did not coimmunoprecipitate with
SFKs, providing a control for specificity (Fig. S1, available at
http://www.jcb.org/cgi/content/full/jcb.200305006/DC1).
We were unable to identify Yes in association with  6 4
immunoprecipitated from the lipid raft fraction (unpub-
lished data), possibly due to the low stoichiometry or relative
Figure 4. Compartmentalization of  6 4 signaling in lipid rafts. (A) After antibody-mediated ligation of  6 4, HaCat cells were lysed with 
Triton X-100 and subjected to OptiPrep™ gradient ultracentrifugation. The lipid raft (R) and Triton X-100–soluble (S) fractions were either 
immunoprecipitated with mAb 3E1 and probed with anti- 4 or anti-pan-Src, or directly probed with antibodies reacting with Yes or Src. The 
lipid raft and Triton X-100–soluble fractions were also immunoprecipitated with mAb 3E1 and subjected to kinase assay or immunoblotting 
with anti-phospho Src Y418. (B) PA-JEB keratinocytes expressing wild-type  4 or  4 Cys 5 were plated on dishes coated with mAb 3E1 for the 
indicated times. Total lysates were probed with anti-phospho Src Y418 or anti- 4 N20. (C) HUVECs transiently transfected with vectors 
encoding  6 4 were left untreated (C) or treated with the SFK inhibitor PP2 or the EGF-R inhibitor AG1478. Cells were plated on dishes 
coated with mAb 3E1 for the indicated times or stimulated with EGF. Total proteins were probed with anti-phospho-ERK and anti-ERK-2. 
(D) HUVECs were transiently transfected with  6 in combination with wild-type  4, phosphorylation-defective  4 (4YF),  4 Cys 5, or tail-less 
 4 (L). Cells were plated for the indicated times on dishes coated with mAb 3E1. Blotting was as in B. (E) PA-JEB keratinocytes stably transduced 
with empty vector (LZRS), wild-type  4, and  4 Cys 5 were deprived of mitogens, detached, and plated on coverslips coated with purified 
laminin-5 or incubated in suspension with mAb 3E1, and were then plated on coverslips coated with anti–mouse IgGs. After 24 h of incubation 
with EGF, the cells were subjected to anti-BrdU staining. The data represent the average and SDs of values obtained from three experiments 
and are expressed as percentage of rescue.T
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instability of the association of  6 4 with Yes and the low
affinity of currently available antibodies reacting specifically
with this kinase. However, immunoblotting experiments in-
dicated that Yes is highly enriched in the lipid raft fraction
of HaCat keratinocytes, whereas Src is not (Fig. 4 A). HaCat
keratinocytes express very low levels of the other pSFK, Fyn
(unpublished data). These results suggest that the lipid raft
fraction of  6 4 is preferentially associated with a pSFK.
To examine if  6 4 activates SFK signaling in lipid rafts,
HaCat cells were subjected to anti- 4 cross-linking and su-
crose gradient fractionation. The lipid raft and the Triton
X-100–soluble fractions were immunoprecipitated with anti-
 4 and subjected to kinase assay or blotting with anti-phos-
pho Src Y418, which monitors phosphorylation of tyrosine
in the activation loop of SFKs. The  6 4-associated pSFK
from the lipid raft fraction underwent autophosphorylation,
as shown by increased incorporation of 
32P and reactivity
with the anti-phospho Src Y418 antibody, and it also phos-
phorylated the exogenous substrate enolase. By contrast, the
Triton X-100–soluble fraction displayed low kinase activity
(Fig. 4 A). Furthermore, we observed that the  4 Cys 5 mu-
tant promoted activation of SFKs less efficiently than wild-
type  4, implying that palmitoylation of  4 is required for
activation of SFKs (Fig. 4 B). These findings indicate that
 6 4 is coupled to SFK signaling in lipid rafts.
To examine the role of lipid rafts in  6 4 signaling to
ERK, we transiently transfected vectors encoding various mu-
tant forms of  6 4 in  4-negative human umbilical venous
endothelial cells (HUVECs; Dans et al., 2001). To confirm
that  6 4 signaling to ERK is mediated by an SFK, cells
transfected with wild-type  6 4 were treated with the SFK
inhibitor PP2. As expected,  6 4-mediated activation of
ERK was suppressed by PP2, but not by the EGF-R inhibitor
AG1478. By contrast, EGF-R–mediated activation of ERK
was inhibited by AG1478, but not by PP2 (Fig. 4 C). Then,
we asked if localization to lipid rafts is necessary for  6 4-
mediated SFK signaling to ERK. Cells were transfected with
constructs encoding  6 in combination with wild-type  4,
phosphorylation-defective  4 (4F), palmitoylation-defective
 4 (Cys 5), or tail-less  4 (L). Immunoblotting showed that
the cells expressed comparable amounts of wild-type, palmi-
toylation-defective, and 4YF  4, and somewhat higher levels
of tail-less  4 (unpublished data). Ligation of wild-type
 6 4 caused activation of ERK, whereas ligation of the
palmitoylation-defective, 4YF, or tail-less mutant did not in-
duce this event (Fig. 4 D). These results indicate that palmi-
toylation of  4 and, by inference, localization of  6 4 to
lipid rafts are necessary for efficient signaling to ERK.
To address the physiological significance of  6 4 incor-
poration in lipid rafts, we examined the ability of  4 Cys 5
to promote EGF-dependent mitogenesis. After synchroniza-
tion in G0, PA-JEB keratinocytes stably transduced with ret-
roviral vectors encoding  4,  4 Cys 5, or empty virus were
plated on laminin-5, or they were incubated with mAb 3E1
and plated on dishes coated with anti–mouse IgGs. BrdU
incorporation and anti-BrdU staining indicated that wild-
type  4 significantly enhanced the ability of PA-JEB kerati-
nocytes to progress through the cell cycle on laminin-5. Sim-
ilar results were obtained after antibody-mediated ligation of
 6 4. By contrast, the palmitoylation-defective  4 was not
able to rescue EGF-mediated proliferation of PA-JEB kerati-
nocytes (Fig. 4 E), providing evidence that  6 4-dependent
mitogenic signaling requires palmitoylation of  4 and incor-
poration of  6 4 in lipid rafts.
Although  6 4, like other integrins, does not contain a
kinase domain, ligation of  6 4 causes phosphorylation of
the cytoplasmic tail of  4, and hence, recruitment of Shc
and other signal transducers. In order for this to occur, the
integrin must associate with a tyrosine kinase. Here, we have
shown that compartmentalization in lipid rafts is necessary
to couple  6 4 to a pSFK and thus reconstitute its ability to
activate signaling and promote epithelial mitogenesis. These
results provide direct evidence that compartmentalization
in lipid rafts is required for  6 4 signaling. Because it
is known that part of the EGF-R localizes to lipid rafts
(Waugh et al., 1999), and our prior analyses have indicated
that the EGF-R activates  4 signaling through the integrin-
associated pSFK (Mariotti et al., 2001), it is possible that in-
corporation in lipid rafts is also necessary for EGF-R–depen-
dent activation of  4 signaling.
How does matrix binding activate  6 4 signaling? At
steady state, only a fraction of  6 4 is palmitoylated, and
hence localized to lipid rafts. However, antibody- or ligand-
induced oligomerization of  6 4 increases the amount of in-
tegrin recovered in the raft fraction, suggesting that matrix
binding to  6 4 increases the integrin’s affinity for lipid rafts.
In addition, palmitoylation is a reversible process (Resh,
1999), allowing for regulated incorporation of  6 4 in lipid
rafts. We envision that matrix-induced aggregation of  6 4-
containing rafts promotes signaling by bringing the integrin
in close proximity to the pSFK, and possibly by excluding a
negative regulatory tyrosine phosphatase, as implied by the
observation that vanadate greatly enhances phosphorylation of
 4 (Dans et al., 2001). In addition, because H-Ras, which is
palmitoylated and localizes to lipid rafts, activates PI-3K more
efficiently than other Ras isoforms (Yan et al., 1998; Roy et
al., 1999), the association with lipid rafts may explain the abil-
ity of  6 4 to activate PI-3K, and hence, Rac, more effec-
tively than other integrins (Shaw et al., 1997). Thus, compart-
mentalization in lipid rafts potentially explains several specific
aspects of  6 4 signaling.
Although other integrins do not appear to be palmitoy-
lated, prior reports suggest that membrane compartmental-
ization plays a role in signaling by many integrins. Certain
 1 and  v integrins associate, through caveolin-1, with pSFKs,
thereby activating Shc signaling to ERK (Wary et al.,
1998). Although these integrins are soluble in Triton X-100,
it is possible that they associate with lipid rafts through a
Triton X-100–sensitive interaction with uPAR, which is
GPI linked and localized to rafts (Wei et al., 1999). The
 3 1,  6 1, and certain other integrins associate with tet-
raspanins (Hemler, 2001). Because many tetraspanins are
palmitoylated and also tend to form oligomers, they could
promote integrin incorporation in lipid raft-like domains.
Accordingly,   6 1 associates with detergent-resistant mi-
crodomains to promote survival signaling in oligodendro-
cytes (Baron et al., 2003). Finally,  v 3,  IIb 3, and  2 1
combine with the integrin-associated protein in cholesterol-
dependent microdomains distinct from classical rafts (Green
et al., 1999), and  4 1 and  L 2 have been shown to colo-T
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calize with the lipid raft marker GM-1 in T cells (Leitinger
and Hogg, 2002). We anticipate that future experiments
will reveal that the mechanism of membrane compartmen-
talization illustrated here also operates, with some variations,
in other integrin-signaling systems.
Materials and methods
Antibodies and chemicals
The antibodies to  4, BPAG-2, and HD-1/plectin were characterized pre-
viously (Hieda et al., 1992; Murgia et al., 1998). Other antibodies and
chemicals were from New England Biolabs, Inc. (anti-phospho-ERK), Santa
Cruz Biotechnology, Inc. (anti-ERK-2, anti-Src N-16, anti-pan Src SRC2,
anti-caveolin-1 N-20, and anti- 4 C-20 and N-20), Transduction Laborato-
ries (anti-Yes mAb), Zymed Laboratories (anti-Transferrin mAb), BD Bio-
sciences (anti-tubulin mAb), CHEMICON International (anti- 3 mAb P1B5
and anti-GFP mAb 2510), Biosource International (anti-phospho-Src Y418
pAb), Calbiochem (PP2 and AG1478), Molecular Probes, Inc. (anti-GFP
A6455), Sigma-Aldrich (saponin and methyl- -cyclodextrin), and Boeh-
ringer (BrdU and anti-BrdU mAb).
Cells, constructs, and expression methods
Vectors encoding human  6,  4, and the  4 mutants B, C, E, and L were
described previously (Spinardi et al., 1993; Mainiero et al., 1997). The  4
Cys mutants were generated with QuikChange
® (Stratagene). HaCat, HU-
VECs, rat bladder 804G, and 293-T HEK cells were transfected as de-
scribed previously (Dans et al., 2001; Mariotti et al., 2001). Immortalized
PA-JEB keratinocytes (Gagnoux-Palacios et al., 1997) were cultured in se-
rum-free keratinocyte growth medium (GIBCO BRL). Retroviral particles
were recovered from Phoenix packaging cells transfected with pLZRS-
IRES-zeo encoding  4 or the  4 Cys 5 mutant, and were used to transduce
PA-JEB keratinocytes.
Biochemical methods
For fractionation, cells were lysed on ice for 30 min with 0.5% Triton
X-100 in TNE (25 mM Tris, pH 7.5, 150 mM NaCl, and 2 mM EDTA) with
inhibitors. After Dounce homogenization, the lysates were subjected to ei-
ther sucrose or OptiPrep™ gradient ultracentrifugation. When indicated,
cells were pretreated with 0.2% saponin for 10 min at 4 C or with 10 mM
M CD for 1 h at 37 C before detergent extraction. To mimic ligand-
induced aggregation of  6 4, cells were detached with EDTA, incubated
in suspension with 10  g/ml anti- 4 mAb 3E1 for 20 min on ice, washed,
and then incubated with 10  g/ml anti–mouse IgGs for 5 min at 37 C. For
immunoblotting, proteins from each fraction were precipitated with TCA.
For immunoprecipitation, the lipid raft and soluble fractions were diluted
with an equal volume of TNE, 1% Triton X-100, and 10% sucrose. After la-
beling with Tran 
35S-label (ICN Biomedicals), IC16 (Peseckis et al., 1993),
or [
3H]palmitate (ICN Biomedicals; Wolven et al., 1997), cells were lysed
in 50 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet
® P-40, 0.5% sodium
deoxycholate, and 2 mM EDTA with phosphatase and protease inhibitors,
and were immunoprecipitated with mAb 3E1. A PhosphorImager was used
to quantify the results. Kinase assays were as described previously (Mariotti
et al., 2001).
Adhesion and immunofluorescence
To test adhesion, cells were plated for 1 h at 4 C or for 30 min in the pres-
ence of anti- 3 on wells coated with laminin-5 matrix (Mariotti et al.,
2001). The relative resistance of PA-JEB keratinocytes to trypsin/EDTA-
induced detachment was measured as described previously (Gagnoux-
Palacios et al., 2001). Cells were fixed with 3.7% PFA and permeabilized
with 0.1% Triton X-100 before immunofluorescent staining.
Cell cycle progression
PA-JEB keratinocytes stably transduced with pLZRS, pLZRS- 4, or pLZRS-
 4 Cys5 were deprived of growth factors, detached, and either plated on
coverslips coated with 5  g/ml human laminin-5 (CHEMICON Interna-
tional) or incubated in suspension with the mAb 3E1 and then plated on
coverslips coated with 10  g/ml anti–mouse IgGs. Cells were cultured for
16 h in serum-free keratinocyte growth medium supplemented with 10 ng/
ml EGF and 50  g/ml bovine pituitary extract, labeled with BrdU, and then
stained with anti-BrdU mAbs. The results were expressed as percentage of
rescue (R), according to the formula R  ([X L]/[F L])   100 (where X is
the percentage of BrdU-positive cells expressing  4 Cys 5; F is the percent-
age of BrdU-positive cells expressing wild-type  4; and L is the percentage
of BrdU-positive cells transduced with pLZRS, on either laminin-5 or the
anti- 4 substrate).
Online supplemental materials
Fig. S1 shows a control for the coimmunoprecipitation of  6 4 with pSFKs
from the lipid raft fraction. HaCat keratinocytes were transiently trans-
fected with a vector encoding a GPI-linked form of GFP, obtained by fus-
ing GFP to the COOH terminus of CD55. After Triton X-100 extraction and
sucrose density fractionation, the lipid raft and the soluble fractions were
immunoprecipitated with anti-GFP mAbs and subjected to blotting with ei-
ther anti panSrc or anti-GFP pAbs. Online supplemental material available
at http://www.jcb.org/cgi/content/full/jcb.200305006/DC1.
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